C J Boylan

423 total citations
8 papers, 372 citations indexed

About

C J Boylan is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, C J Boylan has authored 8 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Epidemiology and 2 papers in Organic Chemistry. Recurrent topics in C J Boylan's work include Pneumocystis jirovecii pneumonia detection and treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and Tuberculosis Research and Epidemiology (2 papers). C J Boylan is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (4 papers), HIV/AIDS drug development and treatment (3 papers) and Tuberculosis Research and Epidemiology (2 papers). C J Boylan collaborates with scholars based in United States and Spain. C J Boylan's co-authors include William L. Current, Thomas Parr, Philip W. Iversen, Carl L. McMillian, Pamela R. Contag, Joseph W. Foley, Darlene E. Jenkins, Heather L. Rocchetta, Diane L. Phillips and Kristina Campanale and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

C J Boylan

8 papers receiving 351 citations

Peers

C J Boylan

ID

MB

EPIDE

PHARM

BE

Christine Sizemore United States

Pierre Santucci France

Frédéric Peyrusson Belgium

Mohan Rao Malaysia

Johannes Putze Germany

Joachim Pfister Austria

Orli Sagi Israel

Kelly Flentie United States

Hiroyasu Koga Japan

Cynthia M. Holsclaw United States

Christine Sizemore United States

C J Boylan

167 ×1.1

ID

295 ×2.1

MB

92 ×0.7

EPIDE

38 ×0.6

PHARM

31 ×0.5

BE

Citations per year, relative to C J Boylan C J Boylan (= 1×) peers Christine Sizemore

Countries citing papers authored by C J Boylan

Since Specialization

Citations

This map shows the geographic impact of C J Boylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Boylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Boylan more than expected).

Fields of papers citing papers by C J Boylan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C J Boylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Boylan. The network helps show where C J Boylan may publish in the future.

Co-authorship network of co-authors of C J Boylan

This figure shows the co-authorship network connecting the top 25 collaborators of C J Boylan. A scholar is included among the top collaborators of C J Boylan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C J Boylan. C J Boylan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Boylan, C J, Kristina Campanale, Philip W. Iversen, et al.. (2003). Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infection. Antimicrobial Agents and Chemotherapy. 47(5). 1700–1706. 68 indexed citations

2.

Dios, Alfonso de, Lourdes Prieto, Almudena Rubio, et al.. (2002). 4-Substituted d-Glutamic Acid Analogues: The First Potent Inhibitors of Glutamate Racemase (MurI) Enzyme with Antibacterial Activity. Journal of Medicinal Chemistry. 45(20). 4559–4570. 54 indexed citations

3.

Rocchetta, Heather L., C J Boylan, Joseph W. Foley, et al.. (2001). Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of Infection. Antimicrobial Agents and Chemotherapy. 45(1). 129–137. 129 indexed citations

4.

Goodwin, Thomas E., C J Boylan, William L. Current, et al.. (2000). Enhanced Pneumocystis carinii activity of new primaquine analogues. Bioorganic & Medicinal Chemistry Letters. 10(19). 2205–2208. 4 indexed citations

5.

Bartlett, Marilyn S., William L. Current, Michael P. Goheen, et al.. (1996). Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 40(8). 1811–1816. 50 indexed citations

6.

Boylan, C J & William L. Current. (1992). Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. Infection and Immunity. 60(4). 1589–1597. 64 indexed citations

7.

Boylan, C J & William L. Current. (1992). An improved rat model of Pneumocystis carinii pneumonia: induced infections in Pneumocystis-free animals.. PubMed. 38(6). 138S–140S. 2 indexed citations

8.

Butler, Thomas F., C J Boylan, Peter Raab, et al.. (1992). Ly295337 a novel cyclic depsipeptide antifungal antibiotic iii resistance development studies. 32. 194. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact